We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.89%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$74.4B
AUM Growth
+$7.26B
(+11%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
19.47%
Holding
3,107
New
25
Increased
2,535
Reduced
421
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$141M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$96.6M |
| 4 |
Amazon
AMZN
|
+$63.7M |
| 5 |
Prologis
PLD
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$56.3M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$36M |
| 3 |
Y
Alleghany Corp
Y
|
+$33M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$26.6M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$20.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.05% |
| 2 | Healthcare | 14.94% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 10% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHCT
1751
Community Healthcare Trust
CHCT
$454M
| $2.15M | ﹤0.01% |
60,144
+1,669
| +3% | +$56.9K |
|
1752
Monarch Casino & Resort
MCRI
$2.23B
| $2.14M | ﹤0.01% |
27,831
-188
| -0.7% | -$14.2K |
|
|
CUTR
1753
DELISTED
Cutera, Inc.
CUTR
| $2.13M | ﹤0.01% |
48,242
+638
| +1% | +$29.1K |
|
1754
Strategy Inc
MSTR
$38.4B
| $2.13M | ﹤0.01% |
150,590
+5,590
| +4% | +$114K |
|
|
ARR
1755
Armour Residential REIT
ARR
$2.36B
| $2.13M | ﹤0.01% |
75,555
+5,317
| +8% | +$145K |
|
1756
John B. Sanfilippo & Son
JBSS
$972M
| $2.13M | ﹤0.01% |
26,146
-780
| -3% | -$63.5K |
|
|
KDNY
1757
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.13M | ﹤0.01% |
81,093
+4,382
| +6% | +$97.1K |
|
1758
RPC Inc
RES
$1.3B
| $2.12M | ﹤0.01% |
238,532
-10,266
| -4% | -$92.7K |
|
1759
Affirm
AFRM
$25.2B
| $2.1M | ﹤0.01% |
217,582
+35,741
| +20% | +$538K |
|
1760
Seaboard Corp
SEB
$4.06B
| $2.1M | ﹤0.01% |
557
+3
| +0.5% | +$11.3K |
|
1761
Bristow Group
VTOL
$1.36B
| $2.1M | ﹤0.01% |
77,505
+5,183
| +7% | +$135K |
|
1762
BJ's Restaurants
BJRI
$1.48B
| $2.1M | ﹤0.01% |
79,664
+8,153
| +11% | +$238K |
|
1763
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
| $2.1M | ﹤0.01% |
14,869
+627
| +4% | +$87.7K |
|
1764
First Busey Corp
BUSE
$2.56B
| $2.09M | ﹤0.01% |
84,581
-3,103
| -4% | -$77.7K |
|
1765
MannKind Corp
MNKD
$1.32B
| $2.08M | ﹤0.01% |
395,697
+9,649
| +2% | +$39.5K |
|
1766
Claros Mortgage Trust
CMTG
$274M
| $2.08M | ﹤0.01% |
141,649
+1,301
| +0.9% | +$20.4K |
|
1767
Herbalife
HLF
$1.29B
| $2.07M | ﹤0.01% |
139,381
+1,476
| +1% | +$25.7K |
|
|
CIM
1768
Chimera Investment
CIM
$1B
| $2.06M | ﹤0.01% |
124,977
-1,544
| -1% | -$28.8K |
|
1769
Movado Group
MOV
$841M
| $2.06M | ﹤0.01% |
63,935
+2,975
| +5% | +$94.9K |
|
1770
Hawkins
HWKN
$2.71B
| $2.05M | ﹤0.01% |
53,174
-1,074
| -2% | -$44.2K |
|
1771
Travere Therapeutics
TVTX
$5.78B
| $2.05M | ﹤0.01% |
97,636
+3,154
| +3% | +$66.8K |
|
1772
Syndax Pharmaceuticals
SNDX
$1.82B
| $2.05M | ﹤0.01% |
80,568
+1,780
| +2% | +$41.5K |
|
1773
Constellium
CSTM
$3.99B
| $2.05M | ﹤0.01% |
173,163
+1,976
| +1% | +$23.1K |
|
|
KYNB
1774
Kyntra Bio
KYNB
$29.4M
| $2.05M | ﹤0.01% |
5,113
+110
| +2% | +$42.1K |
|
|
PGRE
1775
DELISTED
Paramount Group
PGRE
| $2.04M | ﹤0.01% |
342,657
-815
| -0.2% | -$5.09K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, RhumbLine Advisers held 3,107 positions worth $74.4B, up 11% from $67.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
RhumbLine Advisers deployed $2.46B of net new capital in Q4 2022, opening 25 new positions and adding to 2,535 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Steel Dynamics, an estimated $18.8M trimmed.
- RhumbLine Advisers's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
- RhumbLine Advisers added most to Microsoft in Q4 2022, an estimated $141M increase.
- RhumbLine Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $18.8M.
- RhumbLine Advisers fully exited Twitter, Inc. in Q4 2022, selling an estimated $56.3M.
- RhumbLine Advisers's ten largest holdings make up 19% of its $74.4B portfolio in Q4 2022.
- RhumbLine Advisers opened 25 new positions and closed 97 in Q4 2022.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $74.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.